COMMUNIQUÉS West-GlobeNewswire

Protech Home Medical Announces Approval of Corporate Name Change
07/05/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, May 07, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]
More than 60 Hospitals Embrace Artifact Health’s Mobile Technology to Accelerate Physician Query Workflow
07/05/2018
Artifact’s CEO invited to speak at HLTH, the “Future of Healthcare” event, on best practices for ensuring accurate quality data and proper reimbursement BOULDER, Colo., May 07, 2018 (GLOBE NEWSWIRE) -- Artifact Health [...]
Nymox Announces Relocation of Company Headquarters to Switzerland
07/05/2018
HASBROUCK HEIGHTS, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to announce that it has initiated the process of relocating the Company Headquarters from Nassau, [...]
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
07/05/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 7 MAY 2018 at 15.50 EETS Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
07/05/2018
FIT Biotech Oy Company release May 7, 2018 at 3:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 between [...]
Marrone Bio Innovations Appoints Kevin Hammill as New Chief Commercial Officer
07/05/2018
Executive With Proven Track Record Brings MBI Over 25 Years of Agrochemical and Biologicals Experience DAVIS, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading [...]
Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.
07/05/2018
— Scythian Makes $2 Million Investment Alongside Serruya Private Equity, and the Delavaco Group — — Isodiol Recently Awarded the Highly Coveted UK Government Approval for Natural CBD Isolate as an Active Pharmceutical [...]
Alder BioPharmaceuticals® to Present at the 2018 Bank of America Merrill Lynch Health Care Conference
07/05/2018
BOTHELL, Wash., May 07, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
International Stem Cell Corporation Granted Key Patent in US
07/05/2018
CARLSBAD, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based biotechnology company developing novel [...]
Menlo Therapeutics Announces Senior Clinical Leadership Updates
07/05/2018
REDWOOD CITY, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]
Trading by management and close relations of management
07/05/2018
Read the full announcement in the attached file Attachment 2018_27_Trading_by_management_EN
Matinas BioPharma to Host Quarterly Update Conference Call
07/05/2018
Conference call with live audio webcast on Thursday, May 10th at 8:30 am EDT BEDMINSTER, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical [...]
Samumed Presented Multiple Abstracts Supporting Potential Disease Modification at the Osteoarthritis Research Society International (OARSI) 2018 World Congress
07/05/2018
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, a leader in Wnt research and development, presented its most recent clinical and preclinical data for two of the company’s investigational Wnt pathway inhibitors [...]
Foamix Announces Dosing of Last Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
07/05/2018
Top-line Results Expected in the Third Quarter of 2018 REHOVOT, Israel, and BRIDGEWATER, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), a clinical stage specialty pharmaceutical [...]
Daré Bioscience, Inc. Enters into Agreement to Acquire Product to Address Vulvar and Vaginal Atrophy in Hormone Receptor-Positive Breast Cancer Patients
07/05/2018
Agreement intends to broaden Company’s product portfolio within women’s reproductive health with novel clinical candidate, positioning Company with first in class candidates in contraception, sexual health and vaginal [...]
Biotech Industry Veteran Dietmar Berger, M.D., Ph.D., Joins Atara Biotherapeutics as Global Head of Research and Development
07/05/2018
Expanded R&D leadership team focused on rigorous late-stage clinical development and leveraging full potential of Atara’s technology platform SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Atara [...]
Optinose to Report First Quarter 2018 Financial Results and Corporate Updates on May 14, 2018
07/05/2018
Conference Call and Webcast Scheduled for Monday, May 14 at 8:00 a.m. Eastern Time YARDLEY, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, [...]
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
07/05/2018
TUCSON, Ariz. and HUNINGUE, France, May 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and [...]
Rexahn Reports First Quarter 2018 Financial Results
07/05/2018
ROCKVILLE, Md., May 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]

Pages